Report Detail
Global Anti-obesity Drugs Market Insights, Forecast to 2025
- RnM2814744 |
- 30 July, 2020 |
- Global |
- 113 Pages |
- QYResearch |
- Pharma & Healthcare
Anti-obesity Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Anti-obesity Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Anti-obesity Drugs market is segmented into
Peripherally Acting Anti-obesity Drugs
Centrally Acting Anti-obesity Drugs
Segment by Application, the Anti-obesity Drugs market is segmented into
Kids
Adults
Regional and Country-level Analysis
The Anti-obesity Drugs market is analysed and market size information is provided by regions (countries).
The key regions covered in the Anti-obesity Drugs market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Anti-obesity Drugs Market Share Analysis
Anti-obesity Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Anti-obesity Drugs business, the date to enter into the Anti-obesity Drugs market, Anti-obesity Drugs product introduction, recent developments, etc.
The major vendors covered:
Merck
Novo Nordisk
Pfizer
Arena Pharmaceuticals
Roche
GlaxoSmithKline
Orexigen Therapeutics
Vivus
Amylin
Alizyme
Boehringer Ingelheim
Eisai
1 Study Coverage
- 1.1 Anti-obesity Drugs Product Introduction
- 1.2 Market Segments
- 1.3 Key Anti-obesity Drugs Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Anti-obesity Drugs Market Size Growth Rate by Type
- 1.4.2 Peripherally Acting Anti-obesity Drugs
- 1.4.3 Centrally Acting Anti-obesity Drugs
- 1.5 Market by Application
- 1.5.1 Global Anti-obesity Drugs Market Size Growth Rate by Application
- 1.5.2 Kids
- 1.5.3 Adults
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Anti-obesity Drugs Market Size, Estimates and Forecasts
- 2.1.1 Global Anti-obesity Drugs Revenue 2015-2026
- 2.1.2 Global Anti-obesity Drugs Sales 2015-2026
- 2.2 Global Anti-obesity Drugs, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Anti-obesity Drugs Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Anti-obesity Drugs Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Anti-obesity Drugs Competitor Landscape by Players
- 3.1 Anti-obesity Drugs Sales by Manufacturers
- 3.1.1 Anti-obesity Drugs Sales by Manufacturers (2015-2020)
- 3.1.2 Anti-obesity Drugs Sales Market Share by Manufacturers (2015-2020)
- 3.2 Anti-obesity Drugs Revenue by Manufacturers
- 3.2.1 Anti-obesity Drugs Revenue by Manufacturers (2015-2020)
- 3.2.2 Anti-obesity Drugs Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Anti-obesity Drugs Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Anti-obesity Drugs Revenue in 2019
- 3.2.5 Global Anti-obesity Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Anti-obesity Drugs Price by Manufacturers
- 3.4 Anti-obesity Drugs Manufacturing Base Distribution, Product Types
- 3.4.1 Anti-obesity Drugs Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Anti-obesity Drugs Product Type
- 3.4.3 Date of International Manufacturers Enter into Anti-obesity Drugs Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Anti-obesity Drugs Market Size by Type (2015-2020)
- 4.1.1 Global Anti-obesity Drugs Sales by Type (2015-2020)
- 4.1.2 Global Anti-obesity Drugs Revenue by Type (2015-2020)
- 4.1.3 Anti-obesity Drugs Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Anti-obesity Drugs Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Anti-obesity Drugs Sales Forecast by Type (2021-2026)
- 4.2.2 Global Anti-obesity Drugs Revenue Forecast by Type (2021-2026)
- 4.2.3 Anti-obesity Drugs Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Anti-obesity Drugs Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Anti-obesity Drugs Market Size by Application (2015-2020)
- 5.1.1 Global Anti-obesity Drugs Sales by Application (2015-2020)
- 5.1.2 Global Anti-obesity Drugs Revenue by Application (2015-2020)
- 5.1.3 Anti-obesity Drugs Price by Application (2015-2020)
- 5.2 Anti-obesity Drugs Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Anti-obesity Drugs Sales Forecast by Application (2021-2026)
- 5.2.2 Global Anti-obesity Drugs Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Anti-obesity Drugs Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Anti-obesity Drugs by Country
- 6.1.1 North America Anti-obesity Drugs Sales by Country
- 6.1.2 North America Anti-obesity Drugs Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Anti-obesity Drugs Market Facts & Figures by Type
- 6.3 North America Anti-obesity Drugs Market Facts & Figures by Application
7 Europe
- 7.1 Europe Anti-obesity Drugs by Country
- 7.1.1 Europe Anti-obesity Drugs Sales by Country
- 7.1.2 Europe Anti-obesity Drugs Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Anti-obesity Drugs Market Facts & Figures by Type
- 7.3 Europe Anti-obesity Drugs Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Anti-obesity Drugs by Region
- 8.1.1 Asia Pacific Anti-obesity Drugs Sales by Region
- 8.1.2 Asia Pacific Anti-obesity Drugs Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Anti-obesity Drugs Market Facts & Figures by Type
- 8.3 Asia Pacific Anti-obesity Drugs Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Anti-obesity Drugs by Country
- 9.1.1 Latin America Anti-obesity Drugs Sales by Country
- 9.1.2 Latin America Anti-obesity Drugs Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Anti-obesity Drugs Market Facts & Figures by Type
- 9.3 Central & South America Anti-obesity Drugs Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Anti-obesity Drugs by Country
- 10.1.1 Middle East and Africa Anti-obesity Drugs Sales by Country
- 10.1.2 Middle East and Africa Anti-obesity Drugs Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Anti-obesity Drugs Market Facts & Figures by Type
- 10.3 Middle East and Africa Anti-obesity Drugs Market Facts & Figures by Application
11 Company Profiles
- 11.1 Merck
- 11.1.1 Merck Corporation Information
- 11.1.2 Merck Description and Business Overview
- 11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Merck Anti-obesity Drugs Products Offered
- 11.1.5 Merck Related Developments
- 11.2 Novo Nordisk
- 11.2.1 Novo Nordisk Corporation Information
- 11.2.2 Novo Nordisk Description and Business Overview
- 11.2.3 Novo Nordisk Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Novo Nordisk Anti-obesity Drugs Products Offered
- 11.2.5 Novo Nordisk Related Developments
- 11.3 Pfizer
- 11.3.1 Pfizer Corporation Information
- 11.3.2 Pfizer Description and Business Overview
- 11.3.3 Pfizer Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Pfizer Anti-obesity Drugs Products Offered
- 11.3.5 Pfizer Related Developments
- 11.4 Arena Pharmaceuticals
- 11.4.1 Arena Pharmaceuticals Corporation Information
- 11.4.2 Arena Pharmaceuticals Description and Business Overview
- 11.4.3 Arena Pharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Arena Pharmaceuticals Anti-obesity Drugs Products Offered
- 11.4.5 Arena Pharmaceuticals Related Developments
- 11.5 Roche
- 11.5.1 Roche Corporation Information
- 11.5.2 Roche Description and Business Overview
- 11.5.3 Roche Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Roche Anti-obesity Drugs Products Offered
- 11.5.5 Roche Related Developments
- 11.6 GlaxoSmithKline
- 11.6.1 GlaxoSmithKline Corporation Information
- 11.6.2 GlaxoSmithKline Description and Business Overview
- 11.6.3 GlaxoSmithKline Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 GlaxoSmithKline Anti-obesity Drugs Products Offered
- 11.6.5 GlaxoSmithKline Related Developments
- 11.7 Orexigen Therapeutics
- 11.7.1 Orexigen Therapeutics Corporation Information
- 11.7.2 Orexigen Therapeutics Description and Business Overview
- 11.7.3 Orexigen Therapeutics Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Orexigen Therapeutics Anti-obesity Drugs Products Offered
- 11.7.5 Orexigen Therapeutics Related Developments
- 11.8 Vivus
- 11.8.1 Vivus Corporation Information
- 11.8.2 Vivus Description and Business Overview
- 11.8.3 Vivus Sales, Revenue and Gross Margin (2015-2020)
- 11.8.4 Vivus Anti-obesity Drugs Products Offered
- 11.8.5 Vivus Related Developments
- 11.9 Amylin
- 11.9.1 Amylin Corporation Information
- 11.9.2 Amylin Description and Business Overview
- 11.9.3 Amylin Sales, Revenue and Gross Margin (2015-2020)
- 11.9.4 Amylin Anti-obesity Drugs Products Offered
- 11.9.5 Amylin Related Developments
- 11.10 Alizyme
- 11.10.1 Alizyme Corporation Information
- 11.10.2 Alizyme Description and Business Overview
- 11.10.3 Alizyme Sales, Revenue and Gross Margin (2015-2020)
- 11.10.4 Alizyme Anti-obesity Drugs Products Offered
- 11.10.5 Alizyme Related Developments
- 11.1 Merck
- 11.1.1 Merck Corporation Information
- 11.1.2 Merck Description and Business Overview
- 11.1.3 Merck Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Merck Anti-obesity Drugs Products Offered
- 11.1.5 Merck Related Developments
- 11.12 Eisai
- 11.12.1 Eisai Corporation Information
- 11.12.2 Eisai Description and Business Overview
- 11.12.3 Eisai Sales, Revenue and Gross Margin (2015-2020)
- 11.12.4 Eisai Products Offered
- 11.12.5 Eisai Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Anti-obesity Drugs Market Estimates and Projections by Region
- 12.1.1 Global Anti-obesity Drugs Sales Forecast by Regions 2021-2026
- 12.1.2 Global Anti-obesity Drugs Revenue Forecast by Regions 2021-2026
- 12.2 North America Anti-obesity Drugs Market Size Forecast (2021-2026)
- 12.2.1 North America: Anti-obesity Drugs Sales Forecast (2021-2026)
- 12.2.2 North America: Anti-obesity Drugs Revenue Forecast (2021-2026)
- 12.2.3 North America: Anti-obesity Drugs Market Size Forecast by Country (2021-2026)
- 12.3 Europe Anti-obesity Drugs Market Size Forecast (2021-2026)
- 12.3.1 Europe: Anti-obesity Drugs Sales Forecast (2021-2026)
- 12.3.2 Europe: Anti-obesity Drugs Revenue Forecast (2021-2026)
- 12.3.3 Europe: Anti-obesity Drugs Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Anti-obesity Drugs Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Anti-obesity Drugs Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Anti-obesity Drugs Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Anti-obesity Drugs Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Anti-obesity Drugs Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Anti-obesity Drugs Sales Forecast (2021-2026)
- 12.5.2 Latin America: Anti-obesity Drugs Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Anti-obesity Drugs Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Anti-obesity Drugs Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Anti-obesity Drugs Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Anti-obesity Drugs Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Anti-obesity Drugs Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Anti-obesity Drugs Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Anti-obesity Drugs Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Summary:
Get latest Market Research Reports on Anti-obesity Drugs . Industry analysis & Market Report on Anti-obesity Drugs is a syndicated market report, published as Global Anti-obesity Drugs Market Insights, Forecast to 2025. It is complete Research Study and Industry Analysis of Anti-obesity Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
